Raras
Buscar doenças, sintomas, genes...
Distrofia dos cones e bastonetes
ORPHA:1872CID-10 · H35.5CID-11 · 9B70DOENÇA RARA

Problemas de visão genéticos que afetam a retina e são classificados como retinopatias pigmentares.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Problemas de visão genéticos que afetam a retina e são classificados como retinopatias pigmentares.

Pesquisas ativas
7 ensaios
40 total registrados no ClinicalTrials.gov
Publicações científicas
985 artigos
Último publicado: 2026 Mar 31

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
2.5
Europe
Início
Adolescent
+ adult, childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
53 sintomas
💪
Músculos
3 sintomas
👂
Ouvidos
2 sintomas
📏
Crescimento
1 sintomas
🧠
Neurológico
1 sintomas
🧬
Pele e cabelo
1 sintomas

+ 21 sintomas em outras categorias

Características mais comuns

90%prev.
Fotofobia
Muito frequente (99-80%)
90%prev.
Nictalopia
Muito frequente (99-80%)
90%prev.
Anormalidade da pigmentação retiniana
Muito frequente (99-80%)
55%prev.
Pigmentação em espícula óssea da retina
Frequente (79-30%)
55%prev.
Defeito da visão de cores
Frequente (79-30%)
55%prev.
Discromatopsia
Frequente (79-30%)
83sintomas
Muito frequente (3)
Frequente (9)
Ocasional (3)
Sem dados (68)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 83 características clínicas mais associadas, ordenadas por frequência.

FotofobiaPhotophobia
Muito frequente (99-80%)90%
NictalopiaNyctalopia
Muito frequente (99-80%)90%
Anormalidade da pigmentação retinianaAbnormality of retinal pigmentation
Muito frequente (99-80%)90%
Pigmentação em espícula óssea da retinaBone spicule pigmentation of the retina
Frequente (79-30%)55%
Defeito da visão de coresColor vision defect
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico985PubMed
Últimos 10 anos200publicações
Pico202566 papers
Linha do tempo
2026Hoje · 2026🧪 2006Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

33 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive.

TLCD3BCeramide synthaseDisease-causing germline mutation(s) (loss of function) inModerado
FUNÇÃO

Involved in ceramide synthesis

LOCALIZAÇÃO

Golgi apparatus membraneEndoplasmic reticulum membrane

MECANISMO DE DOENÇA

Cone-rod dystrophy 22

An autosomal recessive form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (2)
cone-rod dystrophy 22cone-rod dystrophy
HGNC:25295UniProt:Q71RH2
RLBP1Retinaldehyde-binding protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Soluble retinoid carrier essential the proper function of both rod and cone photoreceptors. Participates in the regeneration of active 11-cis-retinol and 11-cis-retinaldehyde, from the inactive 11-trans products of the rhodopsin photocycle and in the de novo synthesis of these retinoids from 11-trans metabolic precursors. The cycling of retinoids between photoreceptor and adjacent pigment epithelium cells is known as the 'visual cycle'

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)The retinoid cycle in cones (daylight vision)Defective visual phototransduction due to RDH5 loss of function
MECANISMO DE DOENÇA

Bothnia retinal dystrophy

A type of retinitis punctata albescens. Affected individuals show night blindness from early childhood with features consistent with retinitis punctata albescens and macular degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Caudate basal ganglia
11.3 TPM
Córtex cerebral
11.2 TPM
Brain Putamen basal ganglia
10.5 TPM
Brain Frontal Cortex BA9
9.5 TPM
Brain Anterior cingulate cortex BA24
7.6 TPM
OUTRAS DOENÇAS (5)
fundus albipunctatusNewfoundland cone-rod dystrophyBothnia retinal dystrophyretinitis pigmentosa
HGNC:10024UniProt:P12271
RAB28Ras-related protein Rab-28Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes (PubMed:8647132). Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (PubMed:8647132). RAB28 is required for shedding and phagocytosis of cone cell outer segments (OS) discs

LOCALIZAÇÃO

Cell membraneCytoplasm, cytoskeleton, cilium basal bodyCytoplasmNucleus

MECANISMO DE DOENÇA

Cone-rod dystrophy 18

A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
44.8 TPM
Nervo tibial
36.4 TPM
Pituitária
35.5 TPM
Fallopian Tube
33.6 TPM
Cervix Endocervix
32.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 18cone-rod dystrophy
HGNC:9768UniProt:P51157
PRPH2Peripherin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). Required for the correct development and organization of the photoreceptor inner segment (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segmentPhotoreceptor inner segment

MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Ovário
6.8 TPM
Cervix Ectocervix
5.7 TPM
Pituitária
5.3 TPM
Músculo esquelético
5.0 TPM
OUTRAS DOENÇAS (13)
retinitis pigmentosa 7vitelliform macular dystrophy 3fundus albipunctatuschoroidal dystrophy, central areolar 2
HGNC:9942UniProt:P23942
MFSD8Major facilitator superfamily domain-containing protein 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Outward-rectifying chloride channel involved in endolysosomal chloride homeostasis, membrane fusion and function. Conducts chloride currents up to hundreds of picoamperes. Regulates lysosomal calcium content by reducing the lysosomal membrane potential, thereby activating TRPML1 channel and further release of lysosomal calcium ions. Regulates the pH in endolysosomal compartments and may contribute to progressive acidification from endosome to lysosome. Permeable to other halides such as iodide a

LOCALIZAÇÃO

Endosome membraneLysosome membrane

MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 7

A form of neuronal ceroid lipofuscinosis with onset in early childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 7 comprise mixed combinations of granular, curvilinear, fingerprint, and rectilinear profiles.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
20.7 TPM
Ovário
16.8 TPM
Cervix Endocervix
16.7 TPM
Cerebelo
16.7 TPM
Útero
16.4 TPM
OUTRAS DOENÇAS (3)
macular dystrophy with central cone involvementneuronal ceroid lipofuscinosis 7cone-rod dystrophy
HGNC:28486UniProt:Q8NHS3
SEMA4ASemaphorin-4ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Cell surface receptor for PLXNB1, PLXNB2, PLXNB3 and PLXND1 that plays an important role in cell-cell signaling (By similarity). Regulates glutamatergic and GABAergic synapse development (By similarity). Promotes the development of inhibitory synapses in a PLXNB1-dependent manner and promotes the development of excitatory synapses in a PLXNB2-dependent manner (By similarity). Plays a role in priming antigen-specific T-cells, promotes differentiation of Th1 T-helper cells, and thereby contributes

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Other semaphorin interactions
MECANISMO DE DOENÇA

Retinitis pigmentosa 35

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
85.9 TPM
Linfócitos
67.2 TPM
Tireoide
40.6 TPM
Skin Not Sun Exposed Suprapubic
38.2 TPM
Esôfago - Mucosa
36.5 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 35cone-rod dystrophy 10familial colorectal cancer type Xcone-rod dystrophy
HGNC:10729UniProt:Q9H3S1
UNC119Protein unc-119 homolog ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in synaptic functions in photoreceptor cells, the signal transduction in immune cells as a Src family kinase activator, endosome recycling, the uptake of bacteria and endocytosis, protein trafficking in sensory neurons and as lipid-binding chaperone with specificity for a diverse subset of myristoylated proteins. Specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their localization. Binds myristoylated GNAT1 and is required for

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, spindle

VIAS BIOLÓGICAS (1)
Trafficking of myristoylated proteins to the cilium
MECANISMO DE DOENÇA

Immunodeficiency 13

A rare and heterogeneous syndrome defined by a reproducible reduction in the CD4 T-lymphocyte count (less than 300 cells per microliter or less than 20% of total T-cells) in the absence of HIV infection or other known causes of immunodeficiency. IMD13 predisposes to infections and malignancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
57.3 TPM
Testículo
42.6 TPM
Sangue
39.2 TPM
Baço
37.1 TPM
Cerebelo
35.0 TPM
OUTRAS DOENÇAS (3)
cone-rod dystrophy 24idiopathic CD4 lymphocytopeniacone-rod dystrophy
HGNC:12565UniProt:Q13432
GUCA1AGuanylyl cyclase-activating protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Stimulates retinal guanylyl cyclase when free calcium ions concentration is low and inhibits guanylyl cyclase when free calcium ions concentration is elevated (PubMed:18706439, PubMed:19459154, PubMed:30184081, PubMed:30622141). This Ca(2+)-sensitive regulation of retinal guanylyl cyclase is a key event in recovery of the dark state of rod photoreceptors following light exposure (By similarity). May be involved in cone photoreceptor light response and recovery of response in bright light (By sim

LOCALIZAÇÃO

MembranePhotoreceptor inner segmentCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Cone dystrophy 3

An autosomal dominant cone dystrophy. Cone dystrophies are retinal dystrophies characterized by progressive degeneration of the cone photoreceptors with preservation of rod function, as indicated by electroretinogram. However, some rod involvement may be present in some cone dystrophies, particularly at late stage. Affected individuals suffer from photophobia, loss of visual acuity, color vision and central visual field. Another sign is the absence of macular lesions for many years. Cone dystrophies are distinguished from the cone-rod dystrophies in which some loss of peripheral vision also occurs.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
52.1 TPM
Brain Nucleus accumbens basal ganglia
18.0 TPM
Hipotálamo
8.6 TPM
Brain Caudate basal ganglia
7.1 TPM
Brain Putamen basal ganglia
5.5 TPM
OUTRAS DOENÇAS (4)
cone dystrophy 3central areolar choroidal dystrophycone dystrophycone-rod dystrophy
HGNC:4678UniProt:P43080
UBAP1LUbiquitin-associated protein 1-likeDisease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
45.8 TPM
Cerebelo
45.4 TPM
Córtex cerebral
12.0 TPM
Ovário
11.6 TPM
Cervix Ectocervix
11.2 TPM
OUTRAS DOENÇAS (1)
cone-rod dystrophy
HGNC:40028UniProt:F5GYI3
AIPL1Aryl-hydrocarbon-interacting protein-like 1Candidate gene tested inTolerante
FUNÇÃO

May be important in protein trafficking and/or protein folding and stabilization

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 4

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

OUTRAS DOENÇAS (4)
Leber congenital amaurosis 4AIPL1-related retinopathycone-rod dystrophyLeber congenital amaurosis
HGNC:359UniProt:Q9NZN9
RPGRIP1X-linked retinitis pigmentosa GTPase regulator-interacting protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May function as scaffolding protein. Required for normal location of RPGR at the connecting cilium of photoreceptor cells. Required for normal disk morphogenesis and disk organization in the outer segment of photoreceptor cells and for survival of photoreceptor cells

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Leber congenital amaurosis 6

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
40.1 TPM
Baço
1.2 TPM
Intestino delgado
0.7 TPM
Sangue
0.6 TPM
Mama
0.5 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 6cone-rod dystrophy 13Leber congenital amaurosisMeckel syndrome
HGNC:13436UniProt:Q96KN7
OPN1MWMedium-wave-sensitive opsin 1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
OpsinsG alpha (i) signalling eventsThe retinoid cycle in cones (daylight vision)
MECANISMO DE DOENÇA

Colorblindness, partial, deutan series

An X-linked color vision defect characterized by a dichromasy in which red and green are confused, without loss of luminance or shift or shortening of the spectrum. Dichromasy is due to the use of only two types of photoreceptors, blue plus red in deuteranopia and blue plus green in protanopia.

OUTRAS DOENÇAS (4)
red-green color blindnessblue cone monochromacyX-linked cone dysfunction syndrome with myopiacone-rod dystrophy
HGNC:4206UniProt:P04001
CFAP418Cilia- and flagella-associated protein 418Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in photoreceptor outer segment disk morphogenesis (By similarity)

LOCALIZAÇÃO

CytoplasmPhotoreceptor inner segment

MECANISMO DE DOENÇA

Cone-rod dystrophy 16

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (5)
cone-rod dystrophy 16bardet-biedl syndrome 21cone-rod dystrophyretinitis pigmentosa
HGNC:27232UniProt:Q96NL8
PROM1Prominin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in cell differentiation, proliferation and apoptosis (PubMed:24556617). Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner (P

LOCALIZAÇÃO

Apical cell membraneCell projection, microvillus membraneCell projection, cilium, photoreceptor outer segmentEndoplasmic reticulumEndoplasmic reticulum-Golgi intermediate compartment

VIAS BIOLÓGICAS (1)
Developmental Lineage of Pancreatic Ductal Cells
MECANISMO DE DOENÇA

Retinitis pigmentosa 41

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
69.0 TPM
Rim - Medula
33.8 TPM
Cólon transverso
13.8 TPM
Intestino delgado
11.7 TPM
Testículo
8.3 TPM
OUTRAS DOENÇAS (7)
Stargardt disease 4retinitis pigmentosa 41retinal macular dystrophy type 2cone-rod dystrophy 12
HGNC:9454UniProt:O43490
CACNA1FVoltage-dependent L-type calcium channel subunit alpha-1FDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 2A

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

OUTRAS DOENÇAS (4)
congenital stationary night blindness 2AX-linked cone-rod dystrophy 3Aland island eye diseasecone-rod dystrophy
HGNC:1393UniProt:O60840
ADAM9Disintegrin and metalloproteinase domain-containing protein 9Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Metalloprotease that cleaves and releases a number of molecules with important roles in tumorigenesis and angiogenesis, such as TEK, KDR, EPHB4, CD40, VCAM1 and CDH5. May mediate cell-cell, cell-matrix interactions and regulate the motility of cells via interactions with integrins May act as alpha-secretase for amyloid precursor protein (APP)

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (1)
Collagen degradation
MECANISMO DE DOENÇA

Cone-rod dystrophy 9

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 9cone-rod dystrophy
HGNC:216UniProt:Q13443
NMNAT1Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP (PubMed:17402747). Can also use the deamidated form; nicotinic acid mononucleotide (NaMN) as substrate with the same efficiency (PubMed:17402747). Can use triazofurin monophosphate (TrMP) as substrate (PubMed:17402747). Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+) (PubMed:17402747). For the pyrophosphorolytic activity, prefers NAD(+) and NaAD as substrates and degrades NADH, ni

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Nicotinate metabolism
MECANISMO DE DOENÇA

Leber congenital amaurosis 9

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.7 TPM
Tireoide
7.5 TPM
Músculo esquelético
7.0 TPM
Cólon transverso
6.6 TPM
Glândula adrenal
6.3 TPM
OUTRAS DOENÇAS (4)
spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosisLeber congenital amaurosis 9cone-rod dystrophyLeber congenital amaurosis
HGNC:17877UniProt:Q9HAN9
PITPNM3Membrane-associated phosphatidylinositol transfer protein 3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the transfer of phosphatidylinositol and phosphatidylcholine between membranes (in vitro) (By similarity). Binds calcium ions

LOCALIZAÇÃO

Endomembrane system

VIAS BIOLÓGICAS (1)
Synthesis of PI
MECANISMO DE DOENÇA

Cone-rod dystrophy 5

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Baço
95.3 TPM
Cerebelo
77.5 TPM
Cérebro - Hemisfério cerebelar
72.8 TPM
Ovário
51.6 TPM
Córtex cerebral
42.4 TPM
OUTRAS DOENÇAS (2)
cone-rod dystrophy 5cone-rod dystrophy
HGNC:21043UniProt:Q9BZ71
OPN1LWLong-wave-sensitive opsin 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (3)
OpsinsG alpha (i) signalling eventsThe retinoid cycle in cones (daylight vision)
MECANISMO DE DOENÇA

Colorblindness, partial, protan series

An X-linked color vision defect characterized by a dichromasy in which red and green are confused, with loss of luminance and shift of brightness and hue curves toward the short wave end of the spectrum. Dichromasy is due to the use of only two types of photoreceptors, blue plus red in deuteranopia and blue plus green in protanopia.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Rim - Medula
0.0 TPM
OUTRAS DOENÇAS (4)
red color blindnessblue cone monochromacyX-linked cone dysfunction syndrome with myopiacone-rod dystrophy
HGNC:9936UniProt:P04000
CNGA3Cyclic nucleotide-gated channel alpha-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of the cone cyclic nucleotide-gated channel. Mediates cone photoresponses at bright light converting transient changes in intracellular cGMP levels into electrical signals. In the dark, cGMP levels are high and keep the channel open enabling a steady inward current carried by Na(+) and Ca(2+) ions that leads to membrane depolarization and neurotransmitter release from synaptic terminals. Upon photon absorption cGMP levels decline leading to channel closure and membrane hyper

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Achromatopsia 2

An autosomal recessive, ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus.

OUTRAS DOENÇAS (3)
achromatopsia 2cone-rod dystrophyachromatopsia
HGNC:2150UniProt:Q16281
RPGRX-linked retinitis pigmentosa GTPase regulatorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:20631154). GEF activity towards RAB8A may facilitate ciliary trafficking by modulating ciliary intracellular localization of RAB8A (PubMed:20631154). GEF activity towards RAB37 maintains autophagic homeostasis and retinal function (By similarity). Involved in photoreceptor integrity (By similarity). May control cilia formation by regulating ac

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, flagellum axonemeGolgi apparatusCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, cilium axoneme

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 3

An X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.9 TPM
Nervo tibial
17.6 TPM
Tecido adiposo
15.5 TPM
Fallopian Tube
14.7 TPM
Pulmão
14.3 TPM
OUTRAS DOENÇAS (9)
macular degeneration, X-linked atrophicretinitis pigmentosa 3obsolete primary ciliary dyskinesia-retinitis pigmentosa syndromeX-linked cone-rod dystrophy 1
HGNC:10295UniProt:Q92834
DRAM2DNA damage-regulated autophagy modulator protein 2Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Plays a role in the initiation of autophagy. In the retina, might be involved in the process of photoreceptor cells renewal and recycling to preserve visual function. Induces apoptotic cell death when coexpressed with DRAM1

LOCALIZAÇÃO

Lysosome membranePhotoreceptor inner segmentApical cell membrane

MECANISMO DE DOENÇA

Cone-rod dystrophy 21

A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
91.5 TPM
Baço
70.1 TPM
Tecido adiposo
45.1 TPM
Intestino delgado
40.4 TPM
Pulmão
40.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 21cone-rod dystrophy
HGNC:28769UniProt:Q6UX65
GUCY2DRetinal guanylyl cyclase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment (PubMed:15123990, PubMed:21928830, PubMed:26100624, PubMed:30319355, PubMed:9600905). May also participate in the trafficking of membrane-associated proteins to the photoreceptor outer segment membrane (By similarity)

LOCALIZAÇÃO

Photoreceptor outer segment membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Leber congenital amaurosis 1

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.5 TPM
Esôfago - Mucosa
0.7 TPM
Próstata
0.5 TPM
Vagina
0.3 TPM
Glândula salivar
0.3 TPM
OUTRAS DOENÇAS (8)
Leber congenital amaurosis 1night blindness, congenital stationary, type1ichoroidal dystrophy, central areolar, 1cone-rod dystrophy 6
HGNC:4689UniProt:Q02846
RIMS1Regulating synaptic membrane exocytosis protein 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Rab effector involved in exocytosis (By similarity). May act as scaffold protein that regulates neurotransmitter release at the active zone. Essential for maintaining normal probability of neurotransmitter release and for regulating release during short-term synaptic plasticity (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003)

LOCALIZAÇÃO

Cell membraneSynapsePresynaptic cell membrane

VIAS BIOLÓGICAS (6)
Serotonin Neurotransmitter Release CycleGlutamate Neurotransmitter Release CycleNorepinephrine Neurotransmitter Release CycleAcetylcholine Neurotransmitter Release CycleDopamine Neurotransmitter Release Cycle
EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
92.0 TPM
Cerebelo
60.5 TPM
Brain Frontal Cortex BA9
25.2 TPM
Córtex cerebral
21.7 TPM
Brain Anterior cingulate cortex BA24
21.2 TPM
OUTRAS DOENÇAS (1)
cone-rod dystrophy
HGNC:17282UniProt:Q86UR5
RAX2Retina and anterior neural fold homeobox protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in modulating the expression of photoreceptor specific genes. Binds to the Ret-1 and Bat-1 element within the rhodopsin promoter

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Macular degeneration, age-related, 6

A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pituitária
1.9 TPM
Fallopian Tube
0.9 TPM
Útero
0.7 TPM
Cervix Endocervix
0.1 TPM
Testículo
0.1 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 95cone-rod dystrophy 11age related macular degeneration 6cone-rod dystrophy
HGNC:18286UniProt:Q96IS3
CACNA2D4Voltage-dependent calcium channel subunit alpha-2/delta-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Retinal cone dystrophy 4

Characterized by minimal symptoms except for slowly progressive reduction in visual acuity.

OUTRAS DOENÇAS (2)
retinal cone dystrophy 4cone-rod dystrophy
HGNC:20202UniProt:Q7Z3S7
CRXCone-rod homeobox proteinDisease-causing germline mutation(s) inModerado
FUNÇÃO

Transcription factor that binds and transactivates the sequence 5'-TAATC[CA]-3' which is found upstream of several photoreceptor-specific genes, including the opsin genes. Acts synergistically with other transcription factors, such as NRL, RORB and RAX, to regulate photoreceptor cell-specific gene transcription. Essential for the maintenance of mammalian photoreceptors

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Leber congenital amaurosis 7

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Fígado
0.1 TPM
Ovário
0.0 TPM
Cerebelo
0.0 TPM
Cérebro - Hemisfério cerebelar
0.0 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 7cone-rod dystrophy 2retinitis pigmentosacone-rod dystrophy
HGNC:2383UniProt:O43186
CFAP410Cilia- and flagella-associated protein 410Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in cilia formation and/or maintenance (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization (PubMed:21834987). Involved in DNA damage repair (PubMed:26290490)

LOCALIZAÇÃO

MitochondrionCytoplasm, cytoskeleton, cilium basal bodyCell projection, cilium, photoreceptor outer segmentCytoplasm

MECANISMO DE DOENÇA

Retinal dystrophy with or without macular staphyloma

An ocular disorder characterized by decreased vision which worsen over time, and dystrophic changes in the retina, such as retinal pigment epithelium mottling and vessel narrowing. Macular staphyloma, without high myopia, is present in some patients.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
axial spondylometaphyseal dysplasiaretinal dystrophy with or without macular staphylomaamyotrophic lateral sclerosiscone-rod dystrophy
HGNC:1260UniProt:O43822
ABCA4Retinal-specific phospholipid-transporting ATPase ABCA4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leaflet of photoreceptor outer segment disk membranes, where 11-cis-retinylidene-phosphatidylethanolamine is then isomerized to its all-trans isomer and reduced by RDH8 to produce all-trans-retinol. This transport activity ensures that all-trans-retinal generated fr

LOCALIZAÇÃO

MembraneEndoplasmic reticulumCytoplasmic vesicleCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Stargardt disease 1

An autosomal recessive form of Stargardt disease, a retinal degenerative disease characterized by macular dystrophy, progressive bilateral atrophy of the foveal retinal pigment epithelium, and accumulation of fluorescent flecks around the macula and/or in the central and near-peripheral areas of the retina. STGD1 patients typically lose central vision in their first or second decade of life.

OUTRAS DOENÇAS (8)
severe early-childhood-onset retinal dystrophyretinitis pigmentosa 19cone-rod dystrophy 3ABCA4-related retinopathy
HGNC:34UniProt:P78363
ATF6Cyclic AMP-dependent transcription factor ATF-6 alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Precursor of the transcription factor form (Processed cyclic AMP-dependent transcription factor ATF-6 alpha), which is embedded in the endoplasmic reticulum membrane (PubMed:10564271, PubMed:11158310, PubMed:11779464). Endoplasmic reticulum stress promotes processing of this form, releasing the transcription factor form that translocates into the nucleus, where it activates transcription of genes involved in the unfolded protein response (UPR) (PubMed:10564271, PubMed:11158310, PubMed:11779464)

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus membraneNucleus

VIAS BIOLÓGICAS (2)
ATF6 (ATF6-alpha) activates chaperonesModulation of host responses by IFN-stimulated genes
MECANISMO DE DOENÇA

Achromatopsia 7

A form of achromatopsia, an ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus.

OUTRAS DOENÇAS (3)
achromatopsia 7achromatopsiacone-rod dystrophy
HGNC:791UniProt:P18850
POC1BPOC1 centriolar protein homolog BDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Plays an important role in centriole assembly and/or stability and ciliogenesis (PubMed:20008567, PubMed:32060285). Involved in early steps of centriole duplication, as well as in the later steps of centriole length control (PubMed:19109428). Acts in concert with POC1A to ensure centriole integrity and proper mitotic spindle formation (PubMed:32060285). Required for primary cilia formation, ciliary length and also cell proliferation (PubMed:23015594). Required for retinal integrity (PubMed:25044

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, spindle pole

MECANISMO DE DOENÇA

Cone-rod dystrophy 20

A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
18.1 TPM
Nervo tibial
13.1 TPM
Cervix Endocervix
12.9 TPM
Linfócitos
12.7 TPM
Testículo
12.2 TPM
OUTRAS DOENÇAS (2)
cone-rod dystrophy 20cone-rod dystrophy
HGNC:30836UniProt:Q8TC44
TTLL5Tubulin polyglutamylase TTLL5Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Polyglutamylase which modifies tubulin, generating polyglutamate side chains on the gamma-carboxyl group of specific glutamate residues within the C-terminal tail of tubulin. Preferentially mediates ATP-dependent initiation step of the polyglutamylation reaction over the elongation step. Preferentially modifies the alpha-tubulin tail over a beta-tail (By similarity). Required for CCSAP localization to both polyglutamylated spindle and cilia microtubules (PubMed:22493317). Increases the effects o

LOCALIZAÇÃO

Cell projection, ciliumCytoplasm, cytoskeleton, cilium basal bodyNucleusCytoplasm

VIAS BIOLÓGICAS (1)
Carboxyterminal post-translational modifications of tubulin
MECANISMO DE DOENÇA

Cone-rod dystrophy 19

A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
47.0 TPM
Brain Spinal cord cervical c-1
9.7 TPM
Cervix Endocervix
9.4 TPM
Útero
8.6 TPM
Fibroblastos
8.3 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 19cone-rod dystrophy
HGNC:19963UniProt:Q6EMB2
CDHR1Cadherin-related family member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Potential calcium-dependent cell-adhesion protein. May be required for the structural integrity of the outer segment (OS) of photoreceptor cells (By similarity)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Cone-rod dystrophy 15

An autosomal recessive retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (3)
cone-rod dystrophy 15cone-rod dystrophyretinitis pigmentosa
HGNC:14550UniProt:Q96JP9

Variantes genéticas (ClinVar)

479 variantes patogênicas registradas no ClinVar.

🧬 TLCD3B: GRCh38/hg38 16p11.2(chr16:29617341-30154404)x3 ()
🧬 TLCD3B: GRCh38/hg38 16p11.2(chr16:29555975-30178708)x3 ()
🧬 TLCD3B: GRCh38/hg38 16p11.2(chr16:29568701-30291027)x3 ()
🧬 TLCD3B: GRCh37/hg19 16p11.2(chr16:29498472-30199909)x3 ()
🧬 TLCD3B: GRCh37/hg19 16p11.2(chr16:28824858-30321320)x1 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 4,696 variantes classificadas pelo ClinVar.

470
1174
3052
Patogênica (10.0%)
VUS (25.0%)
Benigna (65.0%)
VARIANTES MAIS SIGNIFICATIVAS
RPGR: NM_001034853.2(RPGR):c.171C>A (p.Tyr57Ter) [Likely pathogenic]
CRX: NM_000554.6(CRX):c.692del (p.Gly231fs) [Pathogenic]
CRX: NM_000554.6(CRX):c.821G>A (p.Gly274Asp) [Uncertain significance]
GUCY2D: NM_000180.4(GUCY2D):c.1577G>A (p.Gly526Glu) [Uncertain significance]
GUCY2D: NM_000180.4(GUCY2D):c.1663T>C (p.Tyr555His) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
·Pré-clínico8
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 11 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distrofia dos cones e bastonetes

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

40 ensaios clínicos encontrados, 7 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
559 papers (10 anos)
#1

RGR-mediated photopic visual cycle and oxidative stress: potential mechanisms for cone vision impairment and retinal degeneration in retinitis pigmentosa linked to D1080N-IRBP.

The Journal of neuroscience : the official journal of the Society for Neuroscience2026 Mar 03

Interphotoreceptor retinoid-binding protein (IRBP), an extracellular glycoprotein, supports cone-mediated vision through unclear molecular mechanisms. Over 30 different mutations in the IRBP gene have been found in patients with retinitis pigmentosa, childhood-onset retinal dystrophy with high myopia, and cone-rod dystrophy, yet their pathogenicity and underlying pathogenic mechanisms have not been studied in animal models. Here, we found that extracellular IRBP significantly increased the quantities of the extracellular, but not intracellular, 11-cis-retinol and 11-cis-retinal synthesized by retinal G protein-coupled receptor (RGR) in coordination with retinol dehydrogenases and green light stimuli. Retinoid trafficking in the retina and recovery of S-cone and rod maximum photoresponses were substantially delayed in male and female mice of a new retinitis pigmentosa model linked to the human D1080N-IRBP. The mutant IRBP was unstable, not secreted, and retained in the endoplasmic reticulum of photoreceptors due to formation of insoluble high molecular complexes via disulfide bonds. Young mutant mice exhibited profound reduction in photoresponses to ultraviolet stimuli without a significant S-opsin reduction and S-cone structural degeneration. In contrast, M-cones exhibited early and progressive degeneration, accompanied by mislocalization of M-opsin to the soma and synaptic region of M-cones. Rods also underwent early and progressive degeneration. Oxidative and inflammatory stresses as well as pro-apoptotic proteins such as activated caspase-3, BAX, and apoptosis-inducing factor were markedly increased in the mutant mouse retina. These findings identify both a role of IRBP in the RGR-mediated photopic visual cycle supporting daytime color vision and the molecular mechanism by which D1080N-IRBP causes vision impairment and photoreceptor degeneration.Significance Statement IRBP, an interphotoreceptor matrix protein, supports cone-mediated color vision via unclear mechanism. Mutations in IRBP are associated with blinding diseases with poorly understood pathogenic mechanism. Here, we found that IRBP plays an important role in the RGR-mediated photopic visual cycle essential cone-mediated vision. Consistent with this, recovery of S-cone photoresponse was significantly delayed in a newly developed mouse model carrying a human disease-causing IRBP mutation. This mutation abolished IRBP secretion and led to progressive degeneration of rods and M-cones, accompanied by elevation of oxidative stress, inflammatory cytokines, and proapoptotic proteins in the retina. These results identify both a functional mechanism of IRBP in promoting cone-mediated vision and a pathogenic mechanism by which IRBP mutations cause vision loss and photoreceptor degeneration.

#2

Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.

BMJ open2026 Feb 27

To evaluate the efficacy and safety of advanced therapeutic approaches for inherited retinal disease (IRD) using evidence from systematic reviews and meta-analyses. Umbrella review. We searched for Epistemonikos, PubMed, Scopus, PsycInfo, Google Scholar, Joanna Briggs Institute Evidence Synthesis, the Cochrane Database of Systematic Reviews and Database of Abstracts of Reviews of Effects from inception to November 2024. This included English-language systematic review and meta-analysis assessing advanced therapies in patients with IRD (including congenital retinal dystrophies, retinal dystrophies, retinitis pigmentosa (RP), Stargardt disease, X linked RP, achromatopsia, cone-rod dystrophy, choroideraemia and X linked retinoschisis). Reviews that did not meet the methodological quality threshold were excluded. Two reviewers independently screened and extracted the data, with disagreements resolved by consensus. Findings were synthesised narratively due to the substantial overlap of primary studies. Six systematic reviews and meta-analyses published from 2020 onwards were included, comprising between 6 and 21 primary studies per review. The therapies evaluated included gene therapy, cell-based therapy and stem cell-based interventions. Reported effect estimates showed modest to clinically meaningful improvements in best-corrected visual acuity and retinal structural outcomes in selected IRD subtypes, although effect sizes varied widely across interventions and conditions. The GRADE certainty of evidence ranged from moderate to low, reflecting bias, imprecision and heterogeneity risks. Substantial overlap of primary studies was observed (corrected covered area = 28.9%), precluding quantitative pooling across reviews. The findings suggest notable improvements in visual acuity, retinal structure and other critical outcomes, with therapies such as cell therapy, gene therapy and stem cell therapy showing promising results in enhancing treatment efficacy. Although there are examples of successes with supportive evidence, the overall evidence is not sufficiently strong to make general recommendations, as studies still need to be evaluated on a case-by-case basis. Further high-quality, large-scale randomised controlled trials are needed to better confirm their efficacy and safety.

#3

Novel Genotype-Phenotype Correlations in CRB1-Retinopathies: Insights from Isoforms and Protein Domains Linked to Disease Severity.

Ophthalmology science2026 Feb

This study evaluates genotype-phenotype correlations in CRB1-retinopathies using standardized phenotypic classification and comprehensive analysis of Crumbs homolog 1 (CRB1)-A and CRB1-B involvement alongside in silico protein modeling analysis. Retrospective multicenter cohort study. A total of 389 patients with biallelic disease-causing CRB1 variants from 50 international cohorts, including 73 patients from Moorfields Eye Hospital. Phenotypes were reclassified using standardized diagnostic criteria. Genotype-phenotype correlations were assessed based on CRB1 isoform involvement and protein domain localization of variants, supported by in silico structural modeling. Associations between CRB1 variant location, isoform involvement, and clinical phenotypes including Leber congenital amaurosis/early onset severe retinal dystrophy (LCA/EOSRD), retinitis pigmentosa (RP), cone-rod dystrophy, and macular dystrophy (MD). All patients had variants affecting CRB1-A, with none exclusively affecting CRB1-B. Mutations specific to CRB1-A, sparing CRB1-B were associated with MD. Mutations in exons 6, 7, and 9 were associated to LCA/EOSRD and RP phenotypes, whereas exon 2 variants were linked to MD. Genotype-phenotype correlations included c.1841G>T p.(Gly614Val) linked to LCA/EOSRD and variants exclusively involving exon 11 and 12. Similarly, the variants c.2506C>A p.(Pro836Thr) and c.498_506del p.(Ile167_Gly169del) were linked to MD. Crumbs homolog 1-A must be affected for disease manifestation, while sparing of CRB1-B leads to milder phenotypes. Novel genotype-phenotype correlations were found using standardized phenotypic classification. Understanding protein structure and isoform involvement is crucial for accurate diagnosis, prognosis, and the development of targeted therapies. The authors have no proprietary or commercial interest in any materials discussed in this article.

#4

Saliva Proteomics Shows Immune Activation and Metabolic Shifts in Female Jalili Syndrome Patients.

Oral diseases2026 Mar 24

Jalili syndrome (JS) is an autosomal recessive disorder with cone-rod dystrophy and amelogenesis imperfecta caused by CNNM4 variants. This study describes salivary proteome patterns observed in a small female JS cohort to characterize the oral molecular environment. Unstimulated saliva was collected from three related female JS patients carrying CNNM4 c.1475G>A (p.Gly492Asp) and six age-matched female unaffected controls. Tandem mass tag (TMT)-based quantitative proteomics was performed. Eighty-seven uniquely quantified salivary proteins were identified. Thirty-three proteins showed higher abundance in JS saliva (log2FC > 0.6; adjusted p < 0.05), including neutrophil/innate immune proteins (MPO, CTSG, SERPINB1) and carbohydrate-metabolism enzymes (ENO1/ENO2, GAPDH, TKT, TALDO1). LDHA showed a group-specific detection pattern, being detected in all JS samples but not detected in controls under the current workflow. Functional annotation and interaction analyses highlighted themes related to innate immunity and carbohydrate metabolism. In this small female-only cohort, the salivary proteome profile observed in JS was characterized by increased abundance of proteins annotated to innate immune defense and carbohydrate-associated metabolic processes. These findings are descriptive and should be interpreted in the context of oral clinical status.

#5

Clinical Validation of a CRX Variant Leading to a Cone-Rod Dystrophy.

Cureus2026 Feb

Patients with cone-rod dystrophy (CORD) due to CRX mutations have progressive visual impairment characterized by central vision loss, photophobia, and color vision defects. On ophthalmic examination, patients with CRX-associated CORD may have macular abnormalities, changes in the retinal pigment epithelium, and progressive macular degeneration, affecting central visual function. Variants in the CRX gene located on chromosome 19q13 lead to photoreceptor dysfunction and retinal degeneration. Variant classification in CRX presents unique challenges, as approximately half of heterozygous missense variants may be benign, requiring careful phenotype-genotype correlation for accurate pathogenicity determination. Our patient had progressive vision loss, bilateral macular abnormalities, and visual symptoms compatible with CORD. The patient's clinical findings included central visual field defects, reduced multifocal electroretinography responses, and preserved full-field electroretinography consistent with macular-restricted disease. Next-generation sequencing showed a heterozygous, likely pathogenic variant c.166G>A (p.Ala56Thr) located within the homeodomain at residue 56. Comprehensive ophthalmic examination, electrophysiological testing, and genetic studies may all help reach a CORD diagnosis. This case highlights the importance of phenotype-driven variant interpretation for reclassifying CRX variants from "likely pathogenic" to "pathogenic" and raises clinical awareness for the critical role of genotype-phenotype concordance in inherited retinal dystrophies.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC290 artigos no totalmostrando 200

2026

Saliva Proteomics Shows Immune Activation and Metabolic Shifts in Female Jalili Syndrome Patients.

Oral diseases
2026

Clinical Validation of a CRX Variant Leading to a Cone-Rod Dystrophy.

Cureus
2026

RGR-mediated photopic visual cycle and oxidative stress: potential mechanisms for cone vision impairment and retinal degeneration in retinitis pigmentosa linked to D1080N-IRBP.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2026

Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.

BMJ open
2026

CDHR1 variants in a Japanese family with inherited retinal dystrophy and intrafamilial phenotypic variability.

Frontiers in ophthalmology
2026

RPGRorf15 nanopore long-read sequencing improves retinitis pigmentosa molecular diagnosis for men and women.

Human genetics
2026

Cdhr1a and pcdh15b link photoreceptor outer segments with inner segment calyceal processes revealing a potential mechanism for cone-rod dystrophy.

bioRxiv : the preprint server for biology
2026

Novel Genotype-Phenotype Correlations in CRB1-Retinopathies: Insights from Isoforms and Protein Domains Linked to Disease Severity.

Ophthalmology science
2026

CDHR1-Associated Retinal Dystrophies: Expanding the Clinical and Genetic Spectrum with a Hungarian Cohort.

Genes
2026

Nasal Retinal Degeneration Is a Feature of a Subset of CRX-Associated Retinopathies.

Genes
2025

Delayed Clinical Diagnosis of Alström Syndrome in a Resource-Limited Setting: A Case Report From Rural Pakistan.

Cureus
2026

Genotypic and phenotypic landscape of novel RPGR variants in patients from Western Canada.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

Alström syndrome: a cross-sectional and follow-up study of 127 patients in China, highlighting genetic variant spectrum and cardiac features.

Orphanet journal of rare diseases
2025

Identification of a Novel Splice-Site Variant in CACNA1F With Variable Phenotypic Expression in a Chinese Family.

Molecular genetics &amp; genomic medicine
2025

The Specific Pathogenicity Pattern of the Different CRB1 Isoforms Conditions Clinical Severity in Inherited Retinal Dystrophies.

International journal of molecular sciences
2026

Short stature, optic atrophy, and Pelger-Huët anomaly (SOPH) syndrome: report of a case lacking neutrophil morphologic changes and review of literature.

Ophthalmic genetics
2025

Discrete Wavelet Transform Analysis of PERG Signal Energies for Differentiating Retinal Pathologies.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2025

Two genes, one culprit - a functional candidate validation of a SPATA7 deletion in dogs with day blindness/retinal degeneration.

PLoS genetics
2025

Patient-Reported Social Impact of Molecularly Confirmed Macular Dystrophies and Cone-Rod Dystrophies.

Journal of clinical medicine
2025

Clinical and Molecular Findings in PROM1-Associated Inherited Retinal Dystrophies.

Genes
2025

POC1B-associated cone-rod dystrophy with bilateral optic disc swelling: A novel clinical observation.

American journal of ophthalmology case reports
2025

Novel mutation in CNNM4 gene in a Chinese family with Jalili syndrome and literature review.

International journal of ophthalmology
2026

Unveiling Inflammation-Like Retinal Remodeling in CRB1-Associated Inherited Retinal Dystrophies: Insights From a Multicenter Study.

American journal of ophthalmology
2026

[Ophthalmological care of patients with Bardet-Biedl syndrome].

Die Ophthalmologie
2026

Central Retinal Sensitivity Decline in RPGR-Related Retinal Phenotypes.

American journal of ophthalmology
2025

AAV-Mediated Human Prominin-1 Gene Therapy Rescues Photoreceptor Degeneration in Prominin-1 Knockout Model.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Dysfunction of Unc119, a Transducin-Binding Protein, Leads to Cone-Rod Dystrophy through Activating JAK-Stat and NF-κB Inflammatory Pathways in the Mouse Retina.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2025

A Rare Case of Bardet-Biedl Syndrome Caused by a Heterozygous Point Variant in BBS7 and a CNV Involved BBS7.

Molecular syndromology
2025

A novel missense TUBB4B variant outside of the canonical hotspot is associated with cone-rod dystrophy and sensorineural hearing loss.

Ophthalmic genetics
2025

A 15 bp non-canonical splice-site deletion in ABCA4 linked with retinitis pigmentosa and myopia: insights into splicing defects and phenotypic variability.

Molecular biology reports
2025

Deciphering the impact of ABCA4 genetic variants of unknown significance in inherited retinal disease through computational and functional approaches.

Advances in protein chemistry and structural biology
2025

The Undiagnosed Diseases Network (UDN) Solves Ocular Syndromic Diagnostic Dilemmas.

American journal of ophthalmology
2025

Ciliopathy: Alström Syndrome.

Advances in experimental medicine and biology
2025

Progressive Cone Dystrophy and Cone-Rod Dystrophy.

Advances in experimental medicine and biology
2025

A Case of Siblings with End-Stage Kidney Disease and Retinal Degeneration Suggestive of Partial Alström Syndrome.

Nephron
2025

Bardet-Biedl syndrome: a multisystem disorder with rare dermatological manifestations.

JPMA. The Journal of the Pakistan Medical Association
2025

De novo variant in GUCY2D gene causing atypical cone-rod dystrophy in a consanguineous family and literature review.

International journal of ophthalmology
2025

Identification and functional characterization of ABCA4 gene variants in three patients with Stargardt disease or retinitis pigmentosa.

Frontiers in genetics
2025

Tapetal-like reflex in X-linked RPGR-associated retinopathy.

Ophthalmic genetics
2025

Characterisation and prevalence of inherited retinal diseases in the Finnish population reveals enrichment of population-specific phenotypes and causative variants.

The British journal of ophthalmology
2025

Atp1b2Atp1b1 Knock-In Mice Exhibit a Cone-Rod Dystrophy-Like Phenotype.

Cells
2025

Genetic landscape of inherited retinal dystrophies in a Welsh tertiary referral centre.

The British journal of ophthalmology
2025

Female Simplex Carriers of X-Linked Retinal Dystrophies: A Case Series.

Case reports in ophthalmology
2025

Dark Adaptometry as a Diagnostic Tool in Retinal Diseases: Mechanisms and Clinical Utility.

Journal of clinical medicine
2025

Longitudinal study in autosomal recessive PROM1 inherited retinal disease.

Ophthalmic genetics
2025

A case with bilateral C-shaped autofluorescence in retinal degeneration.

American journal of ophthalmology case reports
2025

The pathogenicity of a novel frame-shift variant c.2321delC of PROM1 in an autosomal recessive cone-rod dystrophy pedigree may be associated with augment of autophagy.

Experimental eye research
2025

Elevated Visual Crowding in CRB1-Associated Retinopathies: Understanding Functional Visual Deficits Using Child-Friendly Computerized Testing.

Investigative ophthalmology &amp; visual science
2025

Bilateral macular colobomata: expanded phenotype of PCARE/C2ORF71.

Ophthalmic genetics
2025

A New Phenotypic Expression in a Patient With a Mutation in the CACNA1F Gene.

Cureus
2025

Clinical Applications of the Cone Contrast Test in Ophthalmology and Neurology.

Journal of clinical medicine
2025

Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome.

The Journal of clinical endocrinology and metabolism
2025

Clinical Exome-Based Redefinition and Reclassification of Retinitis Pigmentosa.

Journal of Korean medical science
2025

Variants in CFAP410 cause a range of retinal and skeletal phenotypes.

NPJ genomic medicine
2025

Expanding the Clinical Spectrum of CRB1-Retinopathies: A Novel Genotype-Phenotype Correlation with Macular Dystrophy and Elevated Intraocular Pressure.

International journal of molecular sciences
2025

A novel mutation in CNNM4 is associated with a case of Jalili syndrome in Egypt.

Documenta ophthalmologica. Advances in ophthalmology
2025

Autosomal Dominant RP1 c.2613dupA (p.Arg872Thrfs*2) Variant Retinitis Pigmentosa Shows Linear Loss of the Ellipsoid Zone over Time with Highly Variable Phenotype.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
2025

Assessment of CRB1-Associated Retinopathies Using the S-MAIA Fast Protocol and Spectral-Domain Optical Coherence Tomography.

Biomedicines
2025

Systematic review of genotype-phenotype associations in CRX-associated retinal dystrophies.

BMJ open ophthalmology
2025

Determinants of diagnostic yield in a multi-ethnic Asian inherited retinal disease cohort.

European journal of human genetics : EJHG
2025

Inherited retinal degeneration in Malay and Indian populations of Singapore and Malaysia: a prospective multicentre study.

Ophthalmic genetics
2025

Novel compound heterozygous variants in SIX6 cause a PAX2 like Dysplastic Optic Disc with macular abnormalities without coexistent microphthalmia or cataract.

Ophthalmic genetics
2025

Cone Rod Homeobox (CRX): literature review and new insights.

Ophthalmic genetics
2025

A novel recurrent ARL3 variant c.209G > A p.(Gly70Glu) causes variable non-syndromic dominant retinal dystrophy with defective lipidated protein transport in human retinal stem cell models.

Human molecular genetics
2025

Retinal degeneration in spinocerebellar ataxia type 7: an overview of the current knowledge.

Arquivos brasileiros de oftalmologia
2025

The BXD32 Mouse: A High-Fidelity Model of Chronic Retinal Inflammation and Photoreceptor Degeneration.

Advances in experimental medicine and biology
2025

A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype.

Molecular genetics &amp; genomic medicine
2025

Identification of Novel Variants in the NHS in Four Turkish Patients With Nance-Horan Syndrome.

American journal of medical genetics. Part A
2025

Expansion of genotypic and phenotypic findings in ADAMTS18-related ocular pathology.

American journal of ophthalmology case reports
2025

A Novel Variant in TUBB4B Causes Progressive Cone-Rod Dystrophy and Early Onset Sensorineural Hearing Loss.

Molecular genetics &amp; genomic medicine
2025

Hardy-Rand-Rittler colour vision testing in cone and cone-rod dystrophies: correlation with structural and functional outcome measures.

Eye (London, England)
2025

Neuronal ceroid lipofuscinosis 11 (CLN11) presenting with early-onset cone-rod dystrophy and learning difficulties.

Neurogenetics
2025

Longitudinal Assessment of Structural and Functional Changes in Rod-cone Dystrophy: A 10-year Follow-up Study.

Ophthalmology science
2025

Unraveling the genetic spectrum of inherited deaf-blindness in Portugal.

Orphanet journal of rare diseases
2025

Phosphoribosyl pyrophosphate synthetase 1 (PRPS1) associated retinal degeneration: an international study.

Ophthalmic genetics
2025

RORA-neurodevelopmental disorder: A unique triad of developmental disabilities, cerebellar anomalies, and myoclonic seizures.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Assessing Contrast Sensitivity Function in CRB1-Retinopathies: Exploring Child-Friendly Measures of Visual Function.

Translational vision science &amp; technology
2024

Functional and pathogenic insights into CNNM4 variants in Jalili syndrome.

Scientific reports
2024

Myriad of congenital excavated optic disc anomalies in achondroplasia.

BMJ case reports
2025

A novel homozygous missense variant in POC1B causes cone dystrophy in a consanguineous Pakistani family.

Ophthalmic genetics
2024

Cone-Rod Dystrophy and Progressive Visual Loss as the First Manifestation of Neuronal Ceroid Lipofuscinosis Type 7: A Case Report.

Clinical case reports
2025

Clinical and Histopathologic Findings in Jalili Syndrome.

Ophthalmology. Retina
2025

Lack of retinal degeneration in a Dram2 knockout mouse model.

Vision research
2024

Phenotypic variability of RP1-related inherited retinal dystrophy associated with the c.5797 C > T (p.Arg1933*) variant in the Japanese population.

Scientific reports
2026

Delayed-onset cord1 progressive retinal atrophy in English Springer Spaniels genetically affected with the RPGRIP1 variant.

Veterinary ophthalmology
2024

Alström syndrome-wide clinical variability within the same variant: a case report and literature review.

Frontiers in pediatrics
2024

Acute Angle Closure Glaucoma in a Patient With Jalili-Smith Syndrome.

Cureus
2024

prominin-1-null Xenopus laevis develop subretinal drusenoid-like deposits, cone-rod dystrophy and RPE atrophy.

Journal of cell science
2024

Biallelic Loss-of-Function Variants in UBAP1L and Nonsyndromic Retinal Dystrophies.

JAMA ophthalmology
2024

Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration.

Ophthalmic genetics
2024

A Novel CEP78 Variant Presenting as Cone Dystrophy and Hearing Loss.

Ophthalmic surgery, lasers &amp; imaging retina
2025

Clinical, Genetic, and Histopathological Characteristics of CRX-associated Retinal Dystrophies.

Ophthalmology. Retina
2024

A GUCY2D variant associated cone-rod dystrophy with electronegative ERG: A case report and review.

American journal of ophthalmology case reports
2024

Rod-sparing in a bardet-biedl syndrome patient with mutations in the ARL6 gene.

Documenta ophthalmologica. Advances in ophthalmology
2024

Novel Variants in ABCA4-Related Retinopathies with Structural Re-Assessment of Variants of Uncertain Significance.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
2024

Retinal cells derived from patients with DRAM2-dependent CORD21 dystrophy exhibit key lysosomal enzyme deficiency and lysosomal content accumulation.

Stem cell reports
2024

Detailed phenotype and long-term follow-up of RAB28-associated cone-rod dystrophy.

Ophthalmic genetics
2024

Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes.

Stem cell research &amp; therapy
2024

Clinical characterizations and molecular genetic study of two co-segregating variants in PDZD7 and PDE6C genes leading simultaneously to non-syndromic hearing loss and achromatopsia.

BMC medical genomics
2024

The Clinical and Mutational Spectrum of Bardet-Biedl Syndrome in Saudi Arabia.

Genes
2024

Clinical and Genetic Findings in a Cohort of Patients with PRPF31-Associated Retinal Dystrophy.

American journal of ophthalmology
2024

Prominin-1 null Xenopus laevis develop subretinal drusenoid-like deposits, cone-rod dystrophy, and RPE atrophy.

bioRxiv : the preprint server for biology
2024

Alström Syndrome: A Review Focusing on Its Diverse Clinical Manifestations and Their Etiology as a Ciliopathy.

Yonago acta medica
2024

In Silico CRISPR-Cas-Mediated Base Editing Strategies for Early-Onset, Severe Cone-Rod Retinal Degeneration in Three Crumbs homolog 1 Patients, including the Novel Variant c.2833G>A.

Genes
2024

De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.

BMC medical genomics
2024

Exploring the diverse clinical and variant spectrum of CEP78-associated syndrome: Novel pathogenic variants identified in a case series.

American journal of medical genetics. Part A
2024

Clinical, Ophthalmic, and Genetic Characterization of RPGRIP1-Associated Leber Congenital Amaurosis/Early-Onset Severe Retinal Dystrophy.

American journal of ophthalmology
2024

Nationwide Prevalence of Inherited Retinal Diseases in the Israeli Population.

JAMA ophthalmology
2024

ABCA4-related retinopathies in Lebanon.

Heliyon
2024

Metabolomics facilitates differential diagnosis in common inherited retinal degenerations by exploring their profiles of serum metabolites.

Nature communications
2025

A CASE OF ALSTRÖM SYNDROME WITH A NOVEL VARIANT IN ALMS1 GENE PRESENTING WITH CONE ROD DYSTROPHY AS FIRST FINDING.

Retinal cases &amp; brief reports
2024

Nationwide epidemiologic survey on incidence of macular dystrophy in Japan.

Japanese journal of ophthalmology
2024

IQCB1 (NPHP5)-Retinopathy: Clinical and Genetic Characterization and Natural History.

American journal of ophthalmology
2024

Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy
2024

Disease-specific variant interpretation highlighted the genetic findings in 2325 Japanese patients with retinitis pigmentosa and allied diseases.

Journal of medical genetics
2024

Frequency and Distribution of Ophthalmic Surgical Procedures among Patients with Inherited Retinal Diseases.

Ophthalmology. Retina
2024

Aland Island Eye Disease with Retinoschisis in the Clinical Spectrum of CACNA1F-Associated Retinopathy-A Case Report.

International journal of molecular sciences
2024

PRPH2-Related Retinal Dystrophies: Mutational Spectrum in 103 Families from a Spanish Cohort.

International journal of molecular sciences
2024

Mutational Profile and Retinal Phenotypes of PCARE-Related Cone-Rod Dystrophies in a Mexican Cohort.

Journal of ophthalmology
2024

Structural and functional characterization of an individual with the M285R KCNV2 hypomorphic allele.

Ophthalmic genetics
2024

ATXN7-Related Cone-Rod Dystrophy: The Integrated Functional Evaluation of the Cerebellum (CERMOI) Study.

JAMA ophthalmology
2024

Loss-of-function variants in UBAP1L cause autosomal recessive retinal degeneration.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Novel hemizygous single-nucleotide duplication in RPGR in a patient with retinal dystrophy and sensorineural hearing loss.

Molecular genetics &amp; genomic medicine
2024

A Retrospective Longitudinal Study of 460 Patients with ABCA4-Associated Retinal Disease.

Ophthalmology
2024

Excessive tubulin glutamylation leads to progressive cone-rod dystrophy and loss of outer segment integrity.

Human molecular genetics
2024

Variants in UBAP1L lead to autosomal recessive rod-cone and cone-rod dystrophy.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series.

Frontiers in medicine
2024

Peripapillary vessel density in eyes with cone-rod dystrophy.

PloS one
2023

Protein modeling and in silico analysis to assess pathogenicity of ABCA4 variants in patients with inherited retinal disease.

Molecular vision
2024

Genetics of Retinitis Pigmentosa and Other Hereditary Retinal Disorders in Western Switzerland.

Ophthalmic research
2023

Unique phenotypic-genotypic correlation in Saudi patients with ALMS1 mutations.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2023

Double Hyperautofluorescence Rings as a Sign of CFAP410-related Retinopathy.

Investigative ophthalmology &amp; visual science
2024

Dentofacial manifestations in a child with Jalili syndrome.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2024

HIGH MYOPIA IS COMMON IN PATIENTS WITH X-LINKED RETINOPATHIES: Myopic Maculopathy Analysis.

Retina (Philadelphia, Pa.)
2024

Phenotypic and Genetic Alterations in Adult-Onset Cone and Cone-Rod Dystrophy.

Ophthalmic research
2023

Subluxated cataractous lens and high myopia: An uncommon association in an achondroplasia child.

Oman journal of ophthalmology
2023

Four different gene-related cone-rod dystrophy: clinical and genetic findings in six Chinese families with diverse modes of inheritance.

Frontiers in genetics
2023

Alström's Syndrome, Leber's Hereditary Optic Neuropathy, or Retinitis Pigmentosa? A Case of Misdiagnosis.

Case reports in ophthalmological medicine
2023

Recombinant protein delivery enables modulation of the phototransduction cascade in mouse retina.

Cellular and molecular life sciences : CMLS
2024

Heterogeneity in the progression of retinal pathologies in mice harboring patient mimicking Impg2 mutations.

Human molecular genetics
2023

Application of Electrophysiology in Non-Macular Inherited Retinal Dystrophies.

Journal of clinical medicine
2024

Whole genome sequencing for inherited retinal diseases in the Korean National Project of Bio Big Data.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2024

Sstr2 Defines the Cone Differentiation-Competent Late-Stage Retinal Progenitor Cells in the Developing Mouse Retina.

Stem cells translational medicine
2024

Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.

Ophthalmology. Retina
2023

Pathogenicity and functional analysis of CFAP410 mutations causing cone-rod dystrophy with macular staphyloma.

Frontiers in medicine
2023

The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: A Narrative Review of Pathomolecular Mechanisms for the Development of Cell-Based Therapies.

Biomedicines
2023

Prevalence of inherited retinal diseases in a large Egyptian cohort.

BMC ophthalmology
2023

Exome sequencing in retinal dystrophy patients reveals a novel candidate gene ER membrane protein complex subunit 3.

Heliyon
2023

ABCA4 c.6480-35A>G, a novel branchpoint variant associated with Stargardt disease.

Frontiers in genetics
2023

A natural history study of autosomal dominant GUCY2D-associated cone-rod dystrophy.

Documenta ophthalmologica. Advances in ophthalmology
2023

Progression of Rare Inherited Retinal Dystrophies May Be Monitored by Adaptive Optics Imaging.

Life (Basel, Switzerland)
2023

Foveal Hypoplasia in CRB1-Related Retinopathies.

International journal of molecular sciences
2024

Hypomorphic CDHR1 variants may result in retinitis pigmentosa with relative preservation of cone function.

Ophthalmic genetics
2023

RPGR: Deep Phenotyping and Genetic Characterization With Findings Specific to the 3'-end of ORF15.

Investigative ophthalmology &amp; visual science
2023

Exacerbated response to oxidative stress in the Retinitis Pigmentosa CerklKD/KO mouse model triggers retinal degeneration pathways upon acute light stress.

Redox biology
2023

Molecular characterization of MAP9 in the photoreceptor sensory cilia as a modifier in canine RPGRIP1-associated cone-rod dystrophy.

Frontiers in cellular neuroscience
2023

Danon Disease: Entire LAMP2 Gene Deletion with Unusual Clinical Presentation-Case Report and Review of the Literature.

Genes
2023

Characteristics of Rare Inherited Retinal Dystrophies in Adaptive Optics-A Study on 53 Eyes.

Diagnostics (Basel, Switzerland)
2024

Prevalence and optical coherence tomography analyses of outer retinal tubulations in Chinese population with inherited retinal diseases.

Eye (London, England)
2023

Coats-like Vasculopathy in Inherited Retinal Disease: Prevalence, Characteristics, Genetics, and Management.

Ophthalmology
2023

Progressive Cone-Rod Dystrophy and RPE Dysfunction in Mitfmi/+ Mice.

Genes
2023

The origins of the full-field flash electroretinogram b-wave.

Frontiers in molecular neuroscience
2023

Clinical and Molecular Aspects of C2orf71/PCARE in Retinal Diseases.

International journal of molecular sciences
2023

Gene Augmentation for Autosomal Dominant CRX-Associated Retinopathies.

Advances in experimental medicine and biology
2023

Presumed Unindicated Implantation of Posterior Chamber Phakic Intraocular Lens.

The American journal of case reports
2023

Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6.

Molecular therapy. Methods &amp; clinical development
2023

Comprehensive Genotyping and Phenotyping Analysis of GUCY2D-Associated Rod- and Cone-Dominated Dystrophies.

American journal of ophthalmology
2023

Gene therapy for RAB28: What can we learn from zebrafish?

Vision research
2023

Genetic and Clinical Profile of Retinopathies Due to Disease-Causing Variants in Leber Congenital Amaurosis (LCA)-Associated Genes in a Large German Cohort.

International journal of molecular sciences
2023

Genotypic Profile and Clinical Characteristics of CRX-Associated Retinopathy in Koreans.

Genes
2023

Nationwide genetic analysis of more than 600 families with inherited eye diseases in Argentina.

NPJ genomic medicine
2023

RPGR-Related Retinopathy: Clinical Features, Molecular Genetics, and Gene Replacement Therapy.

Cold Spring Harbor perspectives in medicine
2023

Mouse all-cone retina models of Cav1.4 synaptopathy.

Frontiers in molecular neuroscience
2023

Clinical Heterogeneity in Two Siblings Harbouring a Heterozygous PRPH2 Pathogenic Variant.

Klinische Monatsblatter fur Augenheilkunde
2023

Structural and Pathogenic Impacts of ABCA4 Variants in Retinal Degenerations-An In-Silico Study.

International journal of molecular sciences
2023

Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.

Human molecular genetics
2023

PENTOSAN POLYSULFATE SODIUM (ELMIRON) MACULOPATHY: A Genetic Perspective.

Retina (Philadelphia, Pa.)
2023

Choroidal structure investigated by choroidal vascularity index in patients with inherited retinal diseases.

International journal of retina and vitreous
2023

Natural disease history of a canine model of oligogenic RPGRIP1-cone-rod dystrophy establishes variable effects of previously and newly mapped modifier loci.

Human molecular genetics
2023

A Rare Case of Achondroplasia With Bilateral Developmental Cataract.

Cureus
2023

CDHR1-Related Cone-Rod Dystrophy: Clinical Characteristics, Imaging Findings, and Genetic Test Results-A Case Report.

Medicina (Kaunas, Lithuania)
2023

Genetic Characteristics and Long-Term Follow-Up of Slovenian Patients with RPGR Retinal Dystrophy.

International journal of molecular sciences
2023

Cellular and Molecular Mechanisms of Pathogenesis Underlying Inherited Retinal Dystrophies.

Biomolecules
2023

Biallelic Variants in TULP1 Are Associated with Heterogeneous Phenotypes of Retinal Dystrophy.

International journal of molecular sciences
2023

Longitudinal Structure-Function Evaluation in a Patient with CDHR1-Associated Retinal Dystrophy: Progressive Visual Function Loss with Retinal Remodeling.

Diagnostics (Basel, Switzerland)
2023

Eyes Shut Homolog-Associated Retinal Degeneration: Natural History, Genetic Landscape, and Phenotypic Spectrum.

Ophthalmology. Retina
2023

RPGRIP1-related retinal disease presenting as isolated cone dysfunction.

Ophthalmic genetics
2023

Absence of CEP78 causes photoreceptor and sperm flagella impairments in mice and a human individual.

eLife
2023

RPGRIP1 variant associated with pigmented paravenous chorioretinal atrophy.

European journal of ophthalmology
2022

A mouse model of cone photoreceptor function loss (cpfl9) with degeneration due to a mutation in Gucy2e.

Frontiers in molecular neuroscience
2023

Phenotypic variability in PRPH2 as demonstrated by a family with incomplete penetrance of autosomal dominant cone-rod dystrophy.

Documenta ophthalmologica. Advances in ophthalmology
2023

Prescribing patterns of low vision devices in patients with cone-related dystrophies.

Indian journal of ophthalmology
2023

PRPH2-Associated Retinopathy: Novel Variants and Genotype-Phenotype Correlations.

Ophthalmology. Retina
2022

Investigation of Structural Alterations in Inherited Retinal Diseases: A Quantitative SD-OCT-Analysis of Retinal Layer Thicknesses in Light of Underlying Genetic Mutations.

International journal of molecular sciences
2022

PCYT1A Missense Variant in Vizslas with Disproportionate Dwarfism.

Genes
2023

ROSAH syndrome mimicking chronic uveitis.

Clinical genetics
2022

Various phenotypes of autosomal dominant cone-rod dystrophy with cone-rod homeobox mutation in two Chinese families.

International journal of ophthalmology
2023

Clinical and Molecular Features of a Chinese Cohort With Syndromic and Nonsyndromic Retinal Dystrophies Related to the CEP290 Gene.

American journal of ophthalmology
2022

The impact of modifier genes on cone-rod dystrophy heterogeneity: An explorative familial pilot study and a hypothesis on neurotransmission impairment.

PloS one
2023

Use of the Medmont Dark-Adapted Chromatic Perimeter for Assessing Rod Function in Retinitis Pigmentosa.

Methods in molecular biology (Clifton, N.J.)
Ver todos os 290 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distrofia dos cones e bastonetes.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Distrofia dos cones e bastonetes

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. RGR-mediated photopic visual cycle and oxidative stress: potential mechanisms for cone vision impairment and retinal degeneration in retinitis pigmentosa linked to D1080N-IRBP.
    The Journal of neuroscience : the official journal of the Society for Neuroscience· 2026· PMID 41775632mais citado
  2. Advanced therapeutic approaches for inherited retinal diseases: an umbrella review.
    BMJ open· 2026· PMID 41760155mais citado
  3. Novel Genotype-Phenotype Correlations in CRB1-Retinopathies: Insights from Isoforms and Protein Domains Linked to Disease Severity.
    Ophthalmology science· 2026· PMID 41626423mais citado
  4. Saliva Proteomics Shows Immune Activation and Metabolic Shifts in Female Jalili Syndrome Patients.
    Oral diseases· 2026· PMID 41876952mais citado
  5. Clinical Validation of a CRX Variant Leading to a Cone-Rod Dystrophy.
    Cureus· 2026· PMID 41841063mais citado
  6. Expanding the Clinical and Genetic Spectrum of TTLL5-Associated Retinal Dystrophy: A Single-Center Cohort Study.
    Ophthalmol Retina· 2026· PMID 41933583recente
  7. Early-onset hydroxychloroquine maculopathy: on the importance of genetic work-up.
    Retin Cases Brief Rep· 2026· PMID 41920593recente
  8. Isolated bull's eye maculopathy in two siblings with biallelic TULP1 variants.
    Ophthalmic Genet· 2026· PMID 41912321recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1872(Orphanet)
  2. MONDO:0015993(MONDO)
  3. GARD:10790(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q18553315(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Distrofia dos cones e bastonetes
Compêndio · Raras BR

Distrofia dos cones e bastonetes

ORPHA:1872 · MONDO:0015993
Prevalência
1-9 / 100 000
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive
CID-10
H35.5 · Distrofias hereditárias da retina
CID-11
Ensaios
7 ativos
Início
Adolescent, Adult, Childhood
Prevalência
2.5 (Europe)
MedGen
UMLS
C4085590
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades